Profound Medical Corp. (PRN.TO) TSX

Currency In CAD

AD

Valuation

Market Cap325.61M
Enterprise Value270.7M
P/E Ratio-5.79
PEG Ratio1.02
Price/Sales Ratio11.58
Price/Book Ratio4.38
Enterprise/Revenue9.29
Enterprise/EBITDA-4.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-2.07
Operating Margin-2.03
AD

Management Effectiveness

Return On Assets-0.53
Return On Equity-0.79

Income Statement

Revenue16.38M
Revenue/Share0.52
Gross Profit11.59M
EBITDA-41.41M
Net Income-43.32M
Diluted EPS-1.43

Balance Sheet

Total Cash50.33M
Total Cash/Share1.39
Total Debt7.47M
Total Debt/Equity0.13
Current Ratio6.56
Book Value Per Share1.64

Price History

52-Week Change28.93
52-Week High12.4
52-Week Low5.23
Moving Average 50 Days9.56
Moving Average 200 Days9.21

Statistics

Average Volume12,262
Shares Outstanding30.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateOctober 16, 2019
AD